BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 29967761)

  • 1. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
    Hahne JC; Valeri N
    Front Oncol; 2018; 8():226. PubMed ID: 29967761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay among SNAIL Transcription Factor, MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Regulation of Tumor Growth and Metastasis.
    Skrzypek K; Majka M
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
    Heery R; Finn SP; Cuffe S; Gray SG
    Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28430163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs and Cancer Drug Resistance.
    Gomes BC; Rueff J; Rodrigues AS
    Methods Mol Biol; 2016; 1395():137-62. PubMed ID: 26910073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers.
    Lin X; Qiu J; Hua K
    Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
    Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
    J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
    Gao Z; Fu P; Yu Z; Zhen F; Gu Y
    Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cancer drug resistance and the involvement of noncoding RNAs.
    Xia H; Hui KM
    Curr Med Chem; 2014; 21(26):3029-41. PubMed ID: 24735364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs as potential therapeutic targets in breast cancer.
    Tomar D; Yadav AS; Kumar D; Bhadauriya G; Kundu GC
    Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194378. PubMed ID: 31048026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs are promising targets for stem cell-based cancer therapy.
    Sakamoto N; Honma R; Sekino Y; Goto K; Sentani K; Ishikawa A; Oue N; Yasui W
    Noncoding RNA Res; 2017 Jun; 2(2):83-87. PubMed ID: 30159424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance.
    Li G; Gong J; Cao S; Wu Z; Cheng D; Zhu J; Huang X; Tang J; Yuan Y; Cai W; Zhang H
    Front Oncol; 2021; 11():742149. PubMed ID: 34660304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional role of long noncoding RNA in resistance to anticancer treatment.
    Qu Y; Tan HY; Chan YT; Jiang H; Wang N; Wang D
    Ther Adv Med Oncol; 2020; 12():1758835920927850. PubMed ID: 32536982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
    Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
    Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition.
    Expósito-Villén A; E Aránega A; Franco D
    Noncoding RNA; 2018 May; 4(2):. PubMed ID: 29843425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
    Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
    Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.